Effects of behavioral and drug therapy on nocturia in older incontinent women

J Am Geriatr Soc. 2005 May;53(5):846-50. doi: 10.1111/j.1532-5415.2005.53260.x.

Abstract

Objectives: To examine changes in nocturia from a multicomponent behavioral training program or drug therapy in older women with urge or mixed (urge-predominant) urinary incontinence.

Design: A secondary analysis of data from a prospective, randomized clinical trial.

Setting: Parent trial was an outpatient research protocol in Alabama.

Participants: One hundred ninety-seven women (aged 55-92) with incontinence and urodynamic evidence of bladder dysfunction. At baseline, 131 women (66% of participants) had nocturia.

Intervention: In the parent study, participants received behavioral training, including four sessions of biofeedback-assisted pelvic floor muscle exercises, drug treatment (oxybutynin IR titrated from 2.5 mg per day to 5.0 mg three times a day), or placebo.

Measurements: Participant-completed bladder diaries were used to calculate changes in nocturia.

Results: Behavioral training reduced nocturia by a median 0.50 episodes per night and was significantly more effective than drug treatment (median reduction=0.30 episodes; P=.02) and placebo (median reduction=0.00 episodes; P<.001). Also, drug treatment was more effective than control (P=.007).

Conclusion: Both behavioral training and drug treatment reduced nocturia more than placebo, but behavioral training was the most effective.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Behavior Therapy*
  • Biofeedback, Psychology
  • Female
  • Humans
  • Mandelic Acids / therapeutic use
  • Medical Records
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome
  • Urinary Incontinence / drug therapy
  • Urinary Incontinence / therapy*
  • Urination Disorders / drug therapy
  • Urination Disorders / therapy*

Substances

  • Mandelic Acids
  • oxybutynin